## Clinical Scenario Analysis This patient has a **complex renal cyst** (Bosniak III or IV lesion) with features suggestive of possible malignancy but with preserved renal function and no systemic symptoms. ## Bosniak Classification of Renal Cysts | Bosniak Class | Features | Malignancy Risk | Management | |---|---|---|---| | I | Simple, homogeneous, no enhancement | <1% | No follow-up | | II | Small nodules, thin septa, minimal enhancement | <5% | Follow-up ultrasound/CT | | IIF | Multiple septa, nodular enhancement, larger | 5–10% | Follow-up imaging at 6, 12, 24 months | | III | Thickened septa, nodules, heterogeneous enhancement | 20–50% | **Further imaging ± biopsy ± surgery** | | IV | Obvious renal mass features, frank enhancement | >80% | **Definitive treatment (surgery/ablation)** | **Key Point:** The 4 cm complex cyst with thick enhancing septum is consistent with **Bosniak III**, which requires further characterization before treatment decisions. ## Why MRI Is the Next Step **High-Yield:** MRI provides superior soft-tissue contrast resolution and can: 1. Better characterize the lesion (cystic vs. solid components) 2. Assess for enhancement patterns suggestive of malignancy 3. Evaluate the contralateral kidney 4. Establish baseline for surveillance if diagnosis remains indeterminate **Clinical Pearl:** MRI is preferred over repeat CT for Bosniak III lesions because it avoids radiation and provides better characterization of complex cystic lesions with borderline features. ## Management Algorithm for Bosniak III Lesions ```mermaid flowchart TD A[Complex renal cyst on CT]:::outcome --> B{Bosniak classification?}:::decision B -->|I-II| C[No follow-up or surveillance]:::action B -->|IIF| D[Follow-up imaging at 6, 12, 24 months]:::action B -->|III| E[MRI for further characterization]:::action E --> F{Imaging findings?}:::decision F -->|Clearly malignant| G[Partial or radical nephrectomy]:::action F -->|Indeterminate| H[Percutaneous biopsy or surveillance]:::action F -->|Benign features| I[Surveillance protocol]:::action B -->|IV| J[Definitive treatment: surgery/ablation]:::action ``` **Tip:** Percutaneous biopsy is NOT first-line for Bosniak III lesions. It is considered only after MRI if the diagnosis remains indeterminate and the patient is a poor surgical candidate. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.